UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Review of the epidemiology of overactive bladder

Research and reports in urology, 2016-01, Vol.8 (Issue 1), p.71-76

2016

Volltextzugriff (PDF)

Role of FDG PET/CT in Management of Patients with Prostate Cancer

Seminars in nuclear medicine, 2024-01, Vol.54 (1), p.4-13

2024

Volltextzugriff (PDF)

Impact of the United States Preventive Services Task Force 'D' recommendation on prostate cancer screening and staging

Current opinion in urology, 2017-05, Vol.27 (3), p.205-209

2017

Volltextzugriff (PDF)

Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer

Nature reviews. Urology, 2024-08

2024

Volltextzugriff (PDF)

Low rate of severe-end-stage kidney disease after SABR for localised primary kidney cancer

Radiation oncology (London, England), 2024-02, Vol.19 (1), p.23-23, Article 23

2024

Volltextzugriff (PDF)

Gender differences in overactive bladder

Canadian journal of urology, 2016-02, Vol.23 (Suppl 1), p.2

2016

Volltextzugriff (PDF)

Practice patterns of primary EBRT with and without ADT in prostate cancer treatment

Prostate cancer and prostatic diseases, 2019-03, Vol.22 (1), p.117-124

2019

Volltextzugriff (PDF)

Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell Carcinoma

European urology open science (Online), 2022-10, Vol.44, p.60-68

2022

Volltextzugriff (PDF)

Whom to Treat: Postdiagnostic Risk Assessment with Gleason Score, Risk Models, and Genomic Classifier

Urologic clinics of North America, 2017-11, Vol.44 (4), p.547-555

2017

Volltextzugriff (PDF)

NeoAdjuvant pembrolizumab and STEreotactic radiotherapy prior to nephrectomy for renal cell carcinoma (NAPSTER): A phase II randomised clinical trial

Contemporary clinical trials communications, 2023-06, Vol.33, p.101145, Article 101145

2023

Volltextzugriff (PDF)

Automating the Capture of Structured Pathology Data for Prostate Cancer Clinical Care and Research

JCO clinical cancer informatics, 2019-07 (3), p.1-8

2019

Volltextzugriff (PDF)

Evolving Paradigms in Prostate Cancer: The Integral Role of PSMA PET/CT in Primary Staging and Therapeutic Decision-Making

International journal of radiation oncology, biology, physics, 2024-09

2024

Volltextzugriff (PDF)

Re: First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX-Targeting Peptide, [68Ga]Ga-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma

European urology, 2024-09, Vol.86 (3), p.284-285

2024

Volltextzugriff (PDF)

Re: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence (NOSTONE)

European urology, 2023-09, Vol.84 (3), p.353-354

2023

Volltextzugriff (PDF)

Re: Overall Survival with Adjuvant Pembrolizumab in Renal-cell Carcinoma

European urology, 2024-07

2024

Volltextzugriff (PDF)

MP41-07 PRESENTATION SKILLS IN THE VIRTUAL MEETING ERA – AN ANALYSIS OF #EAU21

The Journal of urology, 2022-05, Vol.207 (Supplement 5)

2022

Volltextzugriff (PDF)

Re: A Comparative Study of Robot-assisted and Open Radical Prostatectomy in 10 790 Men Treated by Highly Trained Surgeons for Both Procedures

European urology, 2020-02, Vol.77 (2), p.285-286

2020

Volltextzugriff (PDF)

High-flow post-traumatic priapism with delayed presentation

BMJ case reports, 2022-04, Vol.15 (4), p.e249513

2022

Volltextzugriff (PDF)

Prostate‐specific membrane antigen positron emission tomography/computed tomography funding grants free access to superior staging for Australian men with prostate cancer

BJU international, 2022-11, Vol.130 (S3), p.8-10

2022

Volltextzugriff (PDF)

Clinical Implications of Basic Research: Exploring the Transformative Potential of Spatial 'Omics in Uro-oncology

European urology, 2024-09

2024

Volltextzugriff (PDF)

Indocyanine green in minimally and maximally invasive genitourinary cancer surgery

BJU international, 2024-04, Vol.133 (4), p.400-402

2024

Volltextzugriff (PDF)

The application of theranostics in different stages of prostate cancer

Future oncology (London, England), 2021-09, Vol.17 (27), p.3637-3644

2021

Volltextzugriff (PDF)

Re: First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX-Targeting Peptide, 68GaGa-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma

European urology, 2024-09, Vol.86 (3), p.284

2024

Volltextzugriff (PDF)

1 – 25 von 51

Suche als RSS-Feed

Aktive Filter

ThemaPathology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(38)

Publikationsform

Artikel
(50)
magazinearticle
(1)

Sprache

Englisch
(51)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(24)
Science & Technology
(24)
Humans
(16)
Male
(13)
Urology & Nephrology
(13)
Prostate Cancer
(10)
Adult
(6)
Female
(6)
Aged
(5)
Middle Aged
(5)
Oncology
(5)
Prostate-Specific Antigen
(5)
Patients
(4)
Urology
(4)
Adolescent
(3)
Aged, 80 And Over
(3)
Dermatology
(3)
Neoadjuvant
(3)
Positron Emission Tomography Computed Tomography - Methods
(3)
Prevalence
(3)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Review of the epidemiology of overactive bladder

Role of FDG PET/CT in Management of Patients with Prostate Cancer

Administering [177Lu]Lu-PSMA-617 Prior to Radical Prostatectomy in Men with High-risk Localised Prostate Cancer (LuTectomy): A Single-centre, Single-arm, Phase 1/2 Study

Impact of the United States Preventive Services Task Force 'D' recommendation on prostate cancer screening and staging

Neoadjuvant lutetium PSMA, the TIME and immune response in high-risk localized prostate cancer

Low rate of severe-end-stage kidney disease after SABR for localised primary kidney cancer

Gender differences in overactive bladder

Practice patterns of primary EBRT with and without ADT in prostate cancer treatment

Impact of Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in the Management of Oligometastatic Renal Cell Carcinoma

Whom to Treat: Postdiagnostic Risk Assessment with Gleason Score, Risk Models, and Genomic Classifier

NeoAdjuvant pembrolizumab and STEreotactic radiotherapy prior to nephrectomy for renal cell carcinoma (NAPSTER): A phase II randomised clinical trial

Automating the Capture of Structured Pathology Data for Prostate Cancer Clinical Care and Research

Evolving Paradigms in Prostate Cancer: The Integral Role of PSMA PET/CT in Primary Staging and Therapeutic Decision-Making

Re: First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX-Targeting Peptide, [68Ga]Ga-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma

Re: Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence (NOSTONE)

Re: Overall Survival with Adjuvant Pembrolizumab in Renal-cell Carcinoma

MP41-07 PRESENTATION SKILLS IN THE VIRTUAL MEETING ERA – AN ANALYSIS OF #EAU21

Re: A Comparative Study of Robot-assisted and Open Radical Prostatectomy in 10 790 Men Treated by Highly Trained Surgeons for Both Procedures

High-flow post-traumatic priapism with delayed presentation

Prostate‐specific membrane antigen positron emission tomography/computed tomography funding grants free access to superior staging for Australian men with prostate cancer

Clinical Implications of Basic Research: Exploring the Transformative Potential of Spatial 'Omics in Uro-oncology

Indocyanine green in minimally and maximally invasive genitourinary cancer surgery

The application of theranostics in different stages of prostate cancer

Re: First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX-Targeting Peptide, 68GaGa-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma

The Dedicated Imaging Post‐Prostatectomy for Enhanced Radiotherapy outcomes (DIPPER) trial protocol: a multicentre, randomised trial of salvage radiotherapy versus surveillance for low‐risk biochemical recurrence after radical prostatectomy

Aktive Filter

Suchergebnisse filtern